Hippeastrum stapfianum ethanol extract (EE) can potentially lead to a new option for Alzheimer’s disease treatment due to the ability to activate PPAR receptors selectively, inhibit AChE, and present antioxidant capacity under the conditions evaluated. Here, ACHE is linked to Alzheimer disease.